{"symbol": "MRSN", "companyName": "Mersana Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.mersana.com", "description": "Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.", "CEO": "Anna Protopapas", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}